1. BioMAX – the first macromolecular crystallography beamline at MAX IV Laboratory. (5th August 2020) Authors: Ursby, Thomas; Åhnberg, Karl; Appio, Roberto; Aurelius, Oskar; Barczyk, Artur; Bartalesi, Antonio; Bjelčić, Monika; Bolmsten, Fredrik; Cerenius, Yngve; Doak, R. Bruce; Eguiraun, Mikel; Eriksson, Thomas; Friel, Ross J.; Gorgisyan, Ishkhan; Gross, Andrea; Haghighat, Vahid; Hennies, Franz; Jagudin, ... Journal: Journal of synchrotron radiation Issue: Volume 27:Part 5(2020) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer incidence and surveillance strategies in individuals with RASopathies. Issue 4 (19th December 2022) Authors: Ney, Gina; Gross, Andrea; Livinski, Alicia; Kratz, Christian P.; Stewart, Douglas R. Other Names: Leoni Chiara guestEditor.; Neri Giovanni guestEditor. Journal: American journal of medical genetics Issue: Volume 190:Issue 4(2022) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTH-102. PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS (PK) OF MIRDAMETINIB IN A NON-HUMAN PRIMATE (NHP) MODEL. (14th November 2022) Authors: McCully, Cynthia Lester; Shearer, Todd; Gross, Andrea; Langseth, Abraham; Peer, Cody; Killoran, Kristin; Garcia, Rafael Cruz; Figg, William; Widemann, Brigitte Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EXTH-65. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS COMPARISON OF BRAF AND MEK INHIBITORS FOLLOWING SINGLE AND EXTENDED ADMINISTRATION IN A PRE-CLINICAL NON-HUMAN PRIMATE MODEL. (11th November 2019) Authors: Lester McCully, Cynthia; Gross, Andrea; Cruz Garcia, Rafael; Shankarappa, Priya; Odabas, Arman; Rodgers, Louis; Peer, Cody; Figg, William; Widemann, Brigitte; Warren, Katherine Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Molecular features and transmission of NDM-producing Enterobacterales in Israeli hospitals. (14th January 2023) Authors: Adler, Amos; Ghosh, Hiren; Gross, Andrea; Rechavi, Amit; Lasnoy, Michal; Assous, Marc V; Geffen, Yuval; Darawshe, Basel; Wiener-Well, Yonit; Grundmann, Hajo; Reuter, Sandra Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 3(2023) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NFB-17. MEK INHIBITOR BINIMETINIB SHOWS CLINICAL ACTIVITY IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1- ASSOCIATED PLEXIFORM NEUROFIBROMAS: A REPORT FROM PNOC AND THE NF CLINICAL TRIALS CONSORTIUM. (4th December 2020) Authors: Mueller, Sabine; Reddy, Alyssa T; Dombi, Eva; Allen, Jeffrey; Packer, Roger; Clapp, Wade; Goldman, Stewart; Schorry, Elizabeth; Tonsgard, James; Blakeley, Jaishri; Ullrich, Nicole J; Gross, Andrea; Walsh, Karin; Thomas, Coretta; Edwards, Lloyd; Prados, Michael; Korf, Bruce; Fisher, Michael J Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN). Issue 2 (22nd June 2018) Authors: Gross, Andrea; Wolters, Pamela; Baldwin, Andrea; Dombi, Eva; Fisher, Michael J; Weiss, Brian; Kim, AeRang; Blakeley, Jaishri; Whitcomb, Patricia; Holmblad, Marielle; Maritin, Staci; Roderick, Marie Claire; Paul, Scott M; Therrien, Janet; Heisey, Kara; Doyle, Austin; Smith, Malcolm; Glod, John; St... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. RARE-04. IMPACT OF LIVE, VIRTUAL EDUCATIONAL SYMPOSIA ON PEDIATRIC NEURO-ONCOLOGIST, NEURO-ONCOLOGIST, AND NEUROSURGEON CONFIDENCE, KNOWLEDGE, AND INTENTION TO EMPLOY TARGETED MEDICAL THERAPIES FOR THEIR PATIENTS WITH NEUROFIBROMATOSIS TYPE 1. (1st June 2021) Authors: Taylor, Bryan; Weaver, Rebecca; Gross, Andrea; Korf, Bruce; Blakeley, Jaishri Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The sixth international RASopathies symposium: Precision medicine—From promise to practice. Issue 3 (11th December 2019) Authors: Gripp, Karen W.; Schill, Lisa; Schoyer, Lisa; Stronach, Beth; Bennett, Anton M.; Blaser, Susan; Brown, Amanda; Burdine, Rebecca; Burkitt‐Wright, Emma; Castel, Pau; Darilek, Sandra; Dias, Alwyn; Dyer, Tuesdi; Ellis, Michelle; Erickson, Gregg; Gelb, Bruce D.; Green, Tamar; Gross, Andrea; Ho, Alan; ... Journal: American journal of medical genetics Issue: Volume 182:Issue 3(2020) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The surgical management of highly unstable fragility fractures of the sacrum with spinopelvic dissociation: A case series and proposal of a surgical treatment algorithm. Issue 10 (October 2022) Authors: Gross, Andrea; Kuttner, Hannes; Shariat, Kaveh; Benninger, Emanuel; Meier, Christoph Journal: Injury Issue: Volume 53:Issue 10(2022) Page Start: 3377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗